Sponsored by Blue Cross Blue Shield of Michigan

Practitioners can help avert opioid-related overdose deaths by increasing patient retention in buprenorphine treatment. The Michigan Department of Licensing and Regulatory Affairs partnered with researchers from Vital Strategies and Johns Hopkins University to study how practices and clinical protocols affect buprenorphine treatment termination rates. Our study found that high-threshold treatment practices were positively associated with buprenorphine treatment termination. This presentation summarizes our research and describes how LARA's new SUB rules can help reduce treatment termination rates.

Presenter(s):
Valencia Lyle, LARA Contractor

Approved for .75 AMA PRA Category Credit(s)™

Registration: FREE

Please submit your questions in advance at rblake@msms.org.

Statement of Accreditation
The Michigan State Medical Society (MSMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The MSMS designates this live activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.